Giulio F. Paciotti - Concepedia

Author

Giulio F. Paciotti

Also Known As

G F Paciotti, G Paciotti, G. F. Paciotti, G. Paciotti, G.F. Paciotti, Gabriel Paciotti, Giulio F Paciotti, Giulio F. Paciotti, Giulio Franco Paciotti, Giulio Paciotti

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

CytImmune (United States)National Institutes of Health National Cancer Institute Virginia Tech University of Minnesota

About

Giulio F. Paciotti is an author at CytImmune (United States) specializing in medicine, nanomedicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.6K
2	Engineering	7	7	1K
3	Allergy	2	2	265
4	Health Sciences	1	1	253
5	Social Sciences	1	1	28

Giulio F. Paciotti

Publications

Citations

H-Index

Page 1

	Year	Citations
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery Giulio F. Paciotti, Lonnie D. Myer, David M. Weinreich, Drug Delivery	2004	1.2K
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine Steven K. Libutti, Giulio F. Paciotti, Adriana A. Byrnes, Clinical Cancer Research	2010	689
Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors Giulio F. Paciotti, David G. I. Kingston, Lawrence Tamarkin Drug Development Research NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringNanomedicine	2006	477
IL-13 expression at the sites of allergen challenge in patients with asthma S K Huang, Haiyin Xiao, Jörg Kleine‐Tebbe, The Journal of Immunology	1995	371
Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery Rachana Visaria, Robert J. Griffin, Brent Williams, Molecular Cancer Therapeutics NanoparticlesFree Tnf-αNanotherapeuticsEngineeringImmunology	2006	264
Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 Roel H. DeRijk, David Michelson, Brian Karp, The Journal of Clinical Endocrinology & Metabolism ImmunologyWhole BloodGlucocorticoidTnf AlphaInflammation	1997	253
Biodistribution of TNF-α-Coated Gold Nanoparticles in An <i>In Vivo</i> Model System Raghav Goel, Neha Shah, Rachana Visaria, Nanomedicine	2009	182
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Andrew L. Feldman, Lawrence Tamarkin, Giulio F. Paciotti, PubMed Healthy SubjectsRenal PathologyPathologyRenal FunctionAngiogenesis	2000	107
Translational considerations for cancer nanomedicine Stęphan T. Stern, Jennifer B. Hall, Lee L. Yu, Journal of Controlled Release NanoparticlesNanomedicineEngineeringTherapeutic NanomaterialsMedicine	2010	94
Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery Giulio F. Paciotti, Jielu Zhao, Shugeng Cao, Bioconjugate Chemistry NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringPaclitaxel Analogs	2016	86

Page 1